Immunoautoradiographic evidence for a loss of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia

Biological Psychiatry

Volumn 41, Issue 6, 1997, Pages 636-643

  Eastwood, Sharon L ^a,c   Kerwin, Robert W ^b   Harrison, Paul J ^a  

^a Univ Depts Psychiat Clin Neurol   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

AMPA receptor; glutamate receptor; hippocampus; human brain; schizophrenia

Indexed keywords

GLUTAMATE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; TEMPORAL LOBE;

ADULT; AGED; AGED, 80 AND OVER; AUTORADIOGRAPHY; CALIBRATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; TEMPORAL LOBE;

EID: 0031004644     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00220-X     Document Type: Article

References (62)

1. Armstrong DM, Ikonomovic MD, Sheffield R, Wenthold RJ (1994): AMPA-selective glutamate receptor subtype immunoreactivity in the entorhinal cortex of non-demented elderly and patients with Alzheimer's disease. Brain Res 639:207-216.
2. Barton AJL, Pearson RCA, Najlerahim A, Harrison PJ (1993): Pre-and postmortem influences on brain RNA. J Neurochem 61:1-11.
3. Bettler B, Mulle C (1995): Review: Neurotransmitter receptors: II. AMPA and kainate receptors. Neuropharmacology 34: 123-139.
4. Blackstone CD, Levey AI, Martin LJ, Price DL, Huganir RL (1992): Immunological detection of glutamate receptor subtypes in human central nervous system. Ann Neurol 31:680-683.
5. Blanchard V, Raisman-Vozari R, Savasta M, et al (1993): Cellular quantification of tyrosine hydroxylase in the rat brain by immunoautoradiography. J Neurochem 61:617-626.
6. Blümcke I, Wolf HK, Hof PR, Morrison JH, Wiestler OD (1995): Regional distribution of the AMPA glutamate receptor subunits GluR2(4) in human hippocampus. Brain Res 682:239-244.
7. Breese CR, Freedman R, Leonard SS (1995): Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res 674:82-90.
8. 2A receptor mRNAs and binding site densities are differentially affected in schizophrenia. Neuropsychophasmacol
9. Carlsson M, Carlsson A (1990): Schizophrenia: A subcortical neurotransmitter imbalance syndrome? Schizophr Bull 16: 425-432.
10. Conti F, Minelli A, Brecha NC (1994): Cellular localization and laminar distribution of AMPA glutamate receptor subunit mRNAs and proteins in rat cerebral cortex. J Comp Neurol 350:241-259.
11. Day NC, Williams TL, Ince PG, Kamboj RK, Lodge D, Shaw PJ (1995): Distribution of AMPA-selective glutamate receptor subunits in the human hippocampus and cerebellum. Mol Brain Res 31:17-32.
12. Deakin JFW, Slater P, Simpson MD, et al (1989): Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem 52:1781-1786.
13. Deutsch SJ, Mastropaolo J, Schwartz BL, Rosse RB, Morishisa JM (1989): A "glutamatergic hypothesis" of schizophrenia: Rationale for pharmacotherapy with glycine. Clin Neuropharmacol 12:1-13.
14. Eastwood SL, Harrison PJ (1995): Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 69:339-343.
15. Eastwood SL, Burnet PWJ, Beckwith J, Kerwin RW, Harrison PJ (1994a): AMPA glutamate receptors and their flip and flop mRNAs in human hippocampus. Neuroreport 5:1325-1328.
16. Eastwood SL, Story P, Burnet PWJ, Heath P, Harrison PJ (1994b): Differential changes in glutamate receptor subunit messenger RNAs in rat brain after haloperidol treatment. J Psychopharmacol 8:196-203.
17. Eastwood SL, McDonald B, Burnet PWJ, Beckwith JP, Kerwin RW, Harrison PJ (1995a): Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Mol Brain Res 29:211-223.
18. Eastwood SL, Burnet PWJ, Harrison PJ (1995b): Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia Neuroscience 66:309-319.
19. Etienne P, Baudry M (1987): Calcium dependent aspects of synaptic plasticity, excitatory amino acid neurotransmission, brain aging and schizophrenia: A unifying hypothesis. Neurobiol Aging 8:362-366.
20. Fitzgerald LW, Deutch AY, Gasic G, Heinemann SF, Nestler EF (1995): Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J Neurosci 15:2453-2461.
21. Harrison PJ (1995a): On the neuropathology of schizophrenia. Neurodevelopmental, neurodegenerative, or both? Neurodegeneration 4:1-12.
22. Harrison PJ (1995b): In vitro brain imaging: Techniques for studying and localising the pathogenesis of psychiatric diseases. In Kerwin RW (ed), Neurobiology and Psychiatry, vol 3. Cambridge, U.K.: Cambridge University Press, pp 157-174.
23. Harrison PJ, Barton AJL, Najlerahim A, Pearson RCA (1990): Distribution of a kainate/AMPA receptor mRNA in normal and Alzheimer brain. Neuroreport 1:149-152.
24. Harrison PJ, McLaughlin D, Kerwin RW (1991): Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 337:450-452.
25. Harrison PJ, Heath PR, Eastwood SL, Burnet PWJ, McDonald B, Pearson RCA (1995): The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: Selective mRNA vulnerability and a comparison with their encoded proteins. Neurosci Lett 200: 151-154.
26. Harrison PJ, Eastwood SL, Esiri MM, Zaidel DW (1996): Cytoarchitectural hippocampal asymmetries in schizophrenia [abstract]. Schizophr Res. 18:180.
27. Hollman M, Heinemann S (1994): Cloned glutamate receptors. Annu Rev Neurosci 17:31-108.
28. Hollman M, O'Shea-Greenfield A, Rogers SW, Heinemann S (1989): Cloning by functional expression of a member of the glutamate receptor gene family. Nature 342:643-648.
29. Hyman BT, Penney JB Jr, Blackstone CD, Young AB (1994): Localization of non-N-methyl-D-aspartate glutamate receptors in normal and Alzheimer hippocampal formation. Ann Neurol 35:31-37.
30. Ikonomovic MD, Sheffield R, Armstrong DM (1995): AMPA-selective glutamate receptor subtype immunoreactivity in the aged human hippocampal formation. J Comp Neurol 359: 239-252.
31. Iversen SD (1995): Interactions between excitatory amino acids and dopamine systems in the forebrain: Implications for schizophrenia. Behav Pharmacol 6:478-491.
32. Javitt DC, Zukin SR (1991): Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
33. Joyce JN, Lexow N, Kim SJ, et al (1992): Distribution of beta-adrenergic receptor subtypes in human post-mortem brain: Alterations in limbic regions of schizophrenics. Synapse 10:228-246.
34. Kerwin RW (1992): A history of frontal and temporal lobe aspects of the neuropharmacology of schizophrenia. J Psychopharmacol 6:230-240.
35. Kerwin RW (1993): Glutamate receptors, microtubule associated proteins and developmental anomaly in schizophrenia: An hypothesis. Psychol Med 23:547-551.
36. Kerwin RW, Patel S, Meldrum BS, Czudek C, Reynolds GP (1988): Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia. Lancet i:583-584.
37. Kerwin RW, Patel S, Meldrum BS (1990): Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience 39:25-32.
38. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B (1980): Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20: 379-383.
39. Lieberman JA, Koreen A (1993): Neurochemistry and neuroendocrinology of schizophrenia: A selective review. Schizophr Bull 19:371-429.
40. Martin LJ, Blackstone CD, Levey AI, Huganir RL, Price DL (1993): AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience 53:327-358.
41. Mattson MP (1989): Cellular signalling mechanisms common to the development and degeneration of neuroarchitecture. A review. Mech Aging Dev 50:103-157.
42. McDonald JW, Johnston MV (1990): Physiological and pathophysiological roles of excitatory aminoacids during central nervous system development. Brain Res Rev 15:41-70.
43. Miller M, Urban J, Dorsa D (1989): Quantification of mRNA in discrete cell groups of brain by in situ hybridization histochemistry. In Conn PJ (ed), Methods in Neuroscience, vol 1, Gene Probes. San Diego Academic Press, pp. 164-181.
44. Moghaddam B (1994): Recent basic findings in support of excitatory amino-acid hypotheses of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 18:859-870.
45. Molnar E, Baude A, Richmond SA, Patel PB, Somogyi P, McIlhinney RAJ (1993): Biochemical and immunocytochemical characterization of antipeptide antibodies to a cloned GluR1 glutamate receptor subunit: Cellular and subcellular distribution in the rat forebrain. Neuroscience 53:307-326.
46. Monaghan DT, Bridges R, Cotman CW (1989): The excitatory amino-acid receptors: Their classes, pharmacology and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29:365-402.
47. Oretti RG, Spurlock G, Buckland PR, McGuffin P (1994): Lack of effect of antipsychotic and antidepressant drugs on glutamate receptor mRNA levels in rat brains. Neurosci Lett 177:39-43.
48. Petralia RS, Wenthold RJ (1992): Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain. J Comp Neurol 318:329-354.
49. Raisman-Vozari R, Hirsch E, Javoy-Agid F, et al (1991): Quantitative autoradiography of tyrosine hydroxylase immunoreactivity in the rat brain. J Neurochem 57:1212-1222.
50. Reynolds GP, Stroud D (1993): Hippocampal benzodiazepine receptors in schizophrenia. J Neural Transm Gen Sect 93: 151-155.
51. Sherman AD, Hegwood TS, Baruah S, Waziri R (1991): Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics. Biol Psychiatry 30:1191-1198.
52. Siegel SJ, Janssen WG, Tullai JW, et al (1995): Distribution of the excitatory amino acid receptor subunits GluR2(4) in the monkey hippocampus and colocalization with subunits GluR5-7 and NMDAR1. J Neurosci 15:2707-2719.
53. Simpson MDC, Slater P, Royston MC, Deakin JFW (1992): Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia. Psychiatry Res 42:273-282.
54. Squires RF, Saederup E (1991): A review of evidence for GABAergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: More support for a continuum hypothesis of "functional" psychosis. Neurochem Res 16:1099-1111.
55. Tan S-E, Wenthold RJ, Soderling TR (1994): Phosphorylation of AMPA-type glutamate receptors by calcium/calmodulin-dependent protein kinase II and protein kinase C in cultured hippocampal neurons. J Neurosci 14:1123-1129.
56. Toru M, Kurumaji A, Ishimaru M (1994): Excitatory amino acids: Implications for psychiatric disorders research. Life Sci 55:1683-1689.
57. Tsai G, Passani LA, Slusher BS, et al (1995): Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 52:829-836.
58. Ulas J, Cotman CW (1993): Excitatory aminoacid receptors in schizophrenia. Schizophr Bull 19:105-117.
59. Vickers JC, Huntley GW, Hof PR, Bederson J, DeFelipe J, Morrison JH (1995): Immunocytochemical localization of non-NMDA ionotropic excitatory amino acid receptor subunits in human neocortex. Brain Res 671:175-180.
60. Wachtel H, Turski L (1990): Glutamate: A new target in schizophrenia. Trends Pharmacol Sci 11:219-220.
61. Weinberger DR (1995): Schizophrenia: From neuropathology to neurodevelopment. Lancet 346:552-557.
62. Yasuda RP, Ikonomovic MD, Sheffield R, Rubin RT, Wolfe BB, Armstrong DM (1995): Reduction of AMPA-selective glutamate receptor subunits in the entorhinal cortex of patients with Alzheimer's disease pathology: A biochemical study. Brain Res 678:161-167.